Few oligo-amenorrheic athletes have vasomotor symptoms

↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Sökning: WFRF:(Rickenlund A) > Few oligo-amenorrhe...

LIBRIS Formathandbok (Information om MARC21)

Fältnamn	Indikatorer	Metadata
000		03013naa a2200361 4500
001		oai:DiVA.org:liu-25942
003		SwePub
008		091008s2000 \| \|\|\|\|\|\|\|\|\|\|\|000 \|\|eng\|
009		oai:prod.swepub.kib.ki.se:16473480
024	7	a https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-259422 URI
024	7	a https://doi.org/10.1016/S0378-5122(99)00115-22 DOI
024	7	a http://kipublications.ki.se/Default.aspx?queryparsed=id:164734802 URI
040		a (SwePub)liud (SwePub)ki
041		a engb eng
042		9 SwePub
072	7	a ref2 swepub-contenttype
072	7	a art2 swepub-publicationtype
100	1	a Hammar, Mats,d 1950-u Östergötlands Läns Landsting,Linköpings universitet,Hälsouniversitetet,Obstetrik och gynekologi,Kirurgiska kliniken i Östergötland med verksamhet i Linköping, Norrköping och Motala4 aut0 (Swepub:liu)matha92
245	1 0	a Few oligo-amenorrheic athletes have vasomotor symptoms
264	1	c 2000
338		a print2 rdacarrier
520		a Objective: To assess whether women with athletic oligo-amenorrhea have vasomotor symptoms. Material and methods: A mailed questionnaire was sent to 252 female athletes about vasomotor symptoms. Identical questions were also mailed to 1523 peri- and postmenopausal women. Results: The prevalence of vasomotor symptoms was low in female athletes with oligo- and amenorrhea and similar to that found in athletes with regular menstruations. The prevalence was significantly lower than in menopausal women. Although more than a third of the menopausal women had hormone replacement therapy, 30% of them still had vasomotor symptoms at least every week compared with only 2% of the oligo-amenorrheic athletes. Conclusion: Vasomotor symptoms are very uncommon in oligo-amenorrheic athletes, although many of them are hypoestrogenic. It was suggested that one factor contributing to these symptoms around menopause is low hypothalamic activity of ▀-endorphins, which makes the thermoregulatory centre labile. On the other hand, supraphysiological activity in hypothalamic ▀-endorphins may cause the oligo-amenorrhea in athletes, but may stabilise the thermoregulatory centre and thus prevent hot flushes. (C) 2000 Elsevier Science Ireland Ltd.
653		a MEDICINE
653		a MEDICIN
700	1	a Hammar-Henriksson, MB4 aut
700	1	a Frisk, J4 aut
700	1	a Rickenlund, Au Karolinska Institutet4 aut
700	1	a Wyon, Yvonne,d 1960-u Östergötlands Läns Landsting,Linköpings universitet,Hälsouniversitetet,Obstetrik och gynekologi,Kirurgiska kliniken i Östergötland med verksamhet i Linköping, Norrköping och Motala4 aut0 (Swepub:liu)yvowy11
710	2	a Linköpings universitetb Hälsouniversitetet4 org
773	0	t Maturitasg 34:3, s. 219-225q 34:3<219-225x 0378-5122x 1873-4111
856	4 8	u https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-25942
856	4 8	u https://doi.org/10.1016/S0378-5122(99)00115-2
856	4 8	u http://kipublications.ki.se/Default.aspx?queryparsed=id:16473480

Hitta via bibliotek

Maturitas (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

Hitta mer i SwePub

Av författaren/redakt...: Hammar, Mats, 19 ...; Hammar-Henriksso ...; Frisk, J; Rickenlund, A; Wyon, Yvonne, 19 ...

Artiklar i publikationen: Maturitas

Av lärosätet: Linköpings universitet; Karolinska Institutet

Sök utanför SwePub

Sök vidare i:: Google; Google Book Search; Google Scholar

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

LIBRIS.kb.se